Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much

PLoS Medicine

Volumn 11, Issue 7, 2014, Pages

  Moynihan, Ray ^a   Henry, David ^b,c   Moons, Karel G M ^d  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HUMAN; MEDICALIZATION; MORTALITY; OUTCOMES RESEARCH; OVERDIAGNOSIS; PATIENT HARM; PATIENT RISK; PROGNOSIS; RISK ASSESSMENT; STRATIFICATION; TREATMENT PLANNING; CLINICAL TRIAL (TOPIC); DIAGNOSIS; NOMENCLATURE; PROCEDURES; STANDARDS; THERAPY;

CLINICAL TRIALS AS TOPIC; DIAGNOSIS; EVIDENCE-BASED MEDICINE; RISK ASSESSMENT; TERMINOLOGY AS TOPIC; THERAPEUTICS;

EID: 84905376872     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001655     Document Type: Article

References (17)

1. Hoffman JR, Cooper RJ, (2012) Overdiagnosis of disease: a modern epidemic. Arch Intern Med 172: 1123-1124.
2. Berwick D, Hackbarth A, (2012) Eliminating waste in US health care. JAMA 307: 1513-1516.
3. Welch G, Schwartz L, Woloshin S (2011) Overdiagnosed: making people sick in pursuit of health. Boston: Beacon Press.
4. Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, et al. (2013) Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med 10: e1001500.
5. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380: 1778-1786 doi:10.1016/S0140-6736(12)61611-0.
6. Moynihan R, Glassock R, Doust J, (2013) Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased. BMJ 347: f4298.
7. Thomas R, Mitchell G, Batstra L, (2013) Attention-deficit/hyperactivity disorder: are we helping or harming? BMJ 347: f6172.
8. Wiener RS, Schwartz LM, Woloshin S, (2011) Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 171: 831-837.
9. Black W, (1998) Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol 27: 116-122.
10. Glasziou P, Irwig L, (1995) An evidence based approach to individualising treatment. BMJ 311: 1356-1359.
11. Kent DM, Rothwell PM, Ioannidis JPA, Altman DG, Hayward RA, (2010) Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 11: 85.
12. Llewelyn DEH (2013) Analysis of clinical trial data by using evidence based triage reduces overdiagnosis [abstract]. Preventing Overdiagnosis Conference; 10-12 September 2013; Hanover, New Hampshire, US.
13. Moons KGM, van Es GA, Deckers JW, Habbema JD, Grobbee DE, (1997) Limitations of sensitivity, specificity, likelihood ratio, and bayes' theorem in assessing diagnostic probabilities: a clinical example. Epidemiology 8: 12-17.
14. Lord SJ, Staub LP, Bossuyt PMM, Irwig LM, (2011) Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ 343: d4684 doi:10.1136/bmj.d4684.
15. (2006) PLoS Medicine disease mongering collection. Available: http://www.ploscollections.org/article/browse/issue/info%3Adoi%2F10.1371%2Fissue.pcol.v07.i02. Accessed 30 April 2014.
16. Koffijberg H, van Zaane B, Moons KGM, (2013) From accuracy to patient outcome and cost-effectiveness evaluations of diagnostic tests and biomarkers: an exemplary modelling study. BMC Med Res Methodol 13: 12.
17. Glasziou P, Moynihan R, Richards T, Godlee F, (2013) Too much medicine: too little care. BMJ 347: f4247.